SC 13D

Company

Tempest Therapeutics, Inc.

Filed

April 1, 2016

Accession Number

0001104659-16-109125

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →